Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
14.17
-0.16 (-1.12%)
Apr 1, 2025, 10:31 AM EDT - Market open
Avanos Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Avanos Medical.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Avanos Medical is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 7, 2024 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 25, 2023 |
| Stifel | Stifel | Hold Reiterates $25 | Hold | Reiterates | $25 | +76.43% | Jun 21, 2023 |
| CL King | CL King | Strong Buy Initiates $31 | Strong Buy | Initiates | $31 | +118.77% | May 22, 2023 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $28 → $26 | Sell | Maintains | $28 → $26 | +83.49% | May 4, 2023 |
Financial Forecast
Revenue This Year
706.35M
from 687.80M
Increased by 2.70%
Revenue Next Year
711.25M
from 706.35M
Increased by 0.69%
EPS This Year
1.15
from -8.53
EPS Next Year
1.30
from 1.15
Increased by 12.89%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 745.5M | 732.2M | 756.0M |
| Avg | 706.4M | 711.3M | 734.4M |
| Low | 661.5M | 683.4M | 705.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 8.4% | 3.7% | 6.3% |
| Avg | 2.7% | 0.7% | 3.3% |
| Low | -3.8% | -3.3% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.21 | 1.35 | 1.50 |
| Avg | 1.15 | 1.30 | 1.46 |
| Low | 1.08 | 1.23 | 1.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 18.0% | 15.9% |
| Avg | - | 12.9% | 12.6% |
| Low | - | 6.8% | 8.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.